Literature DB >> 22908225

Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium-dependent.

Luyun Zou1, Xiaoyuan Zhu-Mauldin, Richard B Marchase, Andrew J Paterson, Jian Liu, Qinglin Yang, John C Chatham.   

Abstract

The posttranslational modification of nuclear and cytosolic proteins by O-linked β-N-acetylglucosamine (O-GlcNAc) has been shown to play an important role in cellular response to stress. Although increases in O-GlcNAc levels have typically been thought to be substrate-driven, studies in several transformed cell lines reported that glucose deprivation increased O-GlcNAc levels by a number of different mechanisms. A major goal of this study therefore was to determine whether in primary cells, such as neonatal cardiomyocytes, glucose deprivation increases O-GlcNAc levels and if so by what mechanism. Glucose deprivation significantly increased cardiomyocyte O-GlcNAc levels in a time-dependent manner and was associated with decreased O-GlcNAcase (OGA) but not O-GlcNAc transferase (OGT) protein. This response was unaffected by either the addition of pyruvate as an alternative energy source or by the p38 MAPK inhibitor SB203580. However, the response to glucose deprivation was blocked completely by glucosamine, but not by inhibition of OGA with 2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate. Interestingly, the CaMKII inhibitor KN93 also significantly reduced the response to glucose deprivation. Lowering extracellular Ca(2+) with EGTA or blocking store operated Ca(2+) entry with SKF96365 also attenuated the glucose deprivation-induced increase in O-GlcNAc. In C2C12 and HEK293 cells both glucose deprivation and heat shock increased O-GlcNAc levels, and CaMKII inhibitor KN93 attenuated the response to both stresses. These results suggest that increased intracellular calcium and subsequent activation of CaMKII play a key role in regulating the stress-induced increase in cellular O-GlcNAc levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908225      PMCID: PMC3464547          DOI: 10.1074/jbc.M112.393207

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.

Authors:  Voraratt Champattanachai; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Cell Physiol       Date:  2006-08-09       Impact factor: 4.249

Review 2.  Hexosamines, insulin resistance, and the complications of diabetes: current status.

Authors:  Maria G Buse
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01       Impact factor: 4.310

3.  Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.

Authors:  Simon A Hawley; David A Pan; Kirsty J Mustard; Louise Ross; Jenny Bain; Arthur M Edelman; Bruno G Frenguelli; D Grahame Hardie
Journal:  Cell Metab       Date:  2005-07       Impact factor: 27.287

4.  Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.

Authors:  R S Haltiwanger; G D Holt; G W Hart
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

5.  Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart.

Authors:  Norbert Fülöp; Meredith M Mason; Kaushik Dutta; Peipei Wang; Amy J Davidoff; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Cell Physiol       Date:  2006-11-29       Impact factor: 4.249

Review 6.  The hexosamine signaling pathway: deciphering the "O-GlcNAc code".

Authors:  Dona C Love; John A Hanover
Journal:  Sci STKE       Date:  2005-11-29

7.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

8.  Location and characterization of the O-GlcNAcase active site.

Authors:  Clifford Toleman; Andrew J Paterson; Jeffrey E Kudlow
Journal:  Biochim Biophys Acta       Date:  2006-02-20

Review 9.  O-GlcNAc modification in diabetes and Alzheimer's disease.

Authors:  Wagner B Dias; Gerald W Hart
Journal:  Mol Biosyst       Date:  2007-08-29

10.  The selectivity of protein kinase inhibitors: a further update.

Authors:  Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

View more
  32 in total

1.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

2.  Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.

Authors:  Sarah Förster; Andrew S Welleford; Judy C Triplett; Rukhsana Sultana; Brigitte Schmitz; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2014-05-23

Review 3.  Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation.

Authors:  Francisco Altamirano; Zhao V Wang; Joseph A Hill
Journal:  J Physiol       Date:  2015-08-02       Impact factor: 5.182

Review 4.  Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Authors:  Susan A Marsh; Helen E Collins; John C Chatham
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

5.  Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway.

Authors:  Zhao V Wang; Yingfeng Deng; Ningguo Gao; Zully Pedrozo; Dan L Li; Cyndi R Morales; Alfredo Criollo; Xiang Luo; Wei Tan; Nan Jiang; Mark A Lehrman; Beverly A Rothermel; Ann-Hwee Lee; Sergio Lavandero; Pradeep P A Mammen; Anwarul Ferdous; Thomas G Gillette; Philipp E Scherer; Joseph A Hill
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

6.  O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses.

Authors:  Erica W Taylor; Kai Wang; Amy R Nelson; Teruko M Bredemann; Kyle B Fraser; Sarah M Clinton; Rosemary Puckett; Richard B Marchase; John C Chatham; Lori L McMahon
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

7.  Expression of messenger RNA encoding two cellular metabolic regulators, AMP-activated protein kinase (AMPK) and O-GlcNAc transferase (OGT), in channel catfish: Their tissue distribution and relationship with changes in food intake.

Authors:  O Abernathy; D Kostner; P Buer; M Dougherty; A Schmidtberger; R Spainhour; A Leiker; M Vides; B Teel; Y Kobayashi
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2019-05-12       Impact factor: 2.320

8.  Glutathione depletion and acute exercise increase O-GlcNAc protein modification in rat skeletal muscle.

Authors:  Tina Tinkara Peternelj; Susan A Marsh; Natalie A Strobel; Aya Matsumoto; David Briskey; Vincent J Dalbo; Patrick S Tucker; Jeff S Coombes
Journal:  Mol Cell Biochem       Date:  2014-11-23       Impact factor: 3.396

Review 9.  The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts.

Authors:  Heidi M Medford; Susan A Marsh
Journal:  Future Cardiol       Date:  2014-11

10.  Characterization of the specificity of O-GlcNAc reactive antibodies under conditions of starvation and stress.

Authors:  Russell A Reeves; Albert Lee; Roger Henry; Natasha E Zachara
Journal:  Anal Biochem       Date:  2014-04-18       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.